Selexis CHO Cells in Suspension-1

WEBINAR:SUREtechnology Platform to Overcome Phenotypic and Genetic Changes in CHO Cells

January 2022

Pierre-Alain Girod, PhD, Chief Science Officer

CHO cell volumetric productivity has significantly increased in the past two decades. However, turning these cells into high-producing factories has created an overall metabolic burden. In response to transgene expression pressure, CHO cells undergo phenotypic and genetic changes for continuous improvement. Selexis’ SUREtechnology Platform™ provides a solution for overcoming the challenges of high productivity tied to metabolic adaptability.



Ready To Learn More?

Access the Webinar!